Sarah Abdelrahman

Plain English
This study examined the effectiveness of a treatment called rose bengal photodynamic therapy (PDT) combined with standard antibiotic therapy for patients with serious eye infections. Researchers found that while this treatment slightly improved vision for those with certain types of fungal infections, it actually worsened vision for others, with an average difference of 0.39 logMAR for Aspergillus infections. Overall, using rose bengal PDT didn’t show significant benefits in improving vision or reducing scarring over six months compared to the standard treatment alone. Who this helps: This research informs doctors on the mixed effectiveness of rose bengal PDT for treating different types of eye infections, guiding better treatment choices for patients.

Plain English
This study looked at the effects of targeted temperature management (TTM), especially therapeutic hypothermia (TH), on children who had a cardiac arrest outside of the hospital. The researchers found that using TH significantly increased the chances of survival by 72% and improved neurological outcomes by 64% compared to keeping normal body temperature. This matters because it suggests that TH could help more children survive with fewer brain injuries after such critical situations. Who this helps: This helps pediatric patients who experience out-of-hospital cardiac arrest and their healthcare providers.

Plain English
Researchers studied a new drug called LAGi-DEL, designed to block a protein (LAG-3) that prevents the immune system from attacking tumors. LAGi-DEL is highly effective, showing the strongest potency ever reported for a small LAG-3 inhibitor, with a binding strength of 97 nanomolar. This drug not only reactivates immune cells but also performs as well as an existing FDA-approved treatment in fighting cancers like acute myeloid leukemia and lung cancer. Who this helps: This benefits cancer patients by potentially offering more effective treatments.

Plain English
This study looked at recent attempts to develop drugs for children that were submitted to the FDA from 2015 to 2022. Out of 211 drug products assessed, 15% (32 drugs) did not get approved for use in children because either they didn't show enough effectiveness, had safety issues, or both. This is important because it highlights ongoing challenges in creating safe and effective medications for children, even as efforts to improve drug development continue. Who this helps: This helps patients, especially children needing new medications, and the doctors who treat them.

Plain English
This study looked at how often malnourished children are excluded from clinical trials for new medications. Out of nearly 10,000 studies reviewed, about 616 (or 35%) had rules that specifically limited participation for children showing signs of malnutrition, with 71% of studies excluding those who are undernourished and 9% for those overnourished. This matters because excluding these children means that the medicines might not be properly tested for the very ones who need them most, leading to risks in treatment effectiveness. Who this helps: This helps pediatricians and malnourished children by encouraging the inclusion of these vulnerable patients in clinical trials to ensure better medication safety and effectiveness.

Plain English
This study looked at the availability of pediatric-friendly medicines for children after they were approved for use between 1998 and 2024. Researchers found that out of 425 drugs, only 188 (or 44%) were available in formulations specifically designed for kids. Additionally, many pediatric-friendly options were discontinued more frequently than adult versions and often had no available generic alternatives, which makes it harder for kids to get the medications they need safely. Who this helps: This benefits pediatric patients and their healthcare providers by highlighting the need for better medication options for children.

Plain English
This study examined the relationship between certain inflammatory markers (interleukin-6, C-reactive protein, and high-sensitivity C-reactive protein) and outcomes for patients with chronic kidney disease (CKD). The researchers found that higher levels of these markers were linked to increased risks of dying and having heart problems; for example, each increase in interleukin-6 raised the risk of death by 52%, and C-reactive protein raised it by 63%. Understanding these links could help doctors better assess risks and plan treatments for CKD patients. Who this helps: Patients with chronic kidney disease and their healthcare providers.

Plain English
This study looked at how adding a medication called tacrolimus to the treatment of fungal keratitis (an eye infection) affects the survival of corneal grafts after surgery. In a group of 13 patients, 9 (or 69%) had good outcomes that made them candidates for further surgery, and on average, patients’ vision improved significantly by 3.5 lines on the vision chart. This matters because it shows that tacrolimus can help reduce complications and improve the success rate of future eye surgeries. Who this helps: Patients with fungal keratitis undergoing corneal surgery.

Plain English
This research studied two types of medications, GLP-1 receptor agonists (GLP-1RAs) and SGLT2 inhibitors (SGLT2is), to see how well they work alongside insulin for adults with type 1 diabetes. The findings showed that GLP-1RAs improved blood sugar levels by lowering a key measurement (HbA1c) by 0.56% and allowed for reduced insulin use, helping patients lose an average of 3.6 kg. On the other hand, SGLT2is also lowered HbA1c by 0.38% and helped reduce insulin needs by 4.7 units per day, but they increased the risk of a serious condition (diabetic ketoacidosis) by more than double. This research is important because it shows that while these medications can help manage diabetes, they come with specific risks that patients and doctors need to consider. Who this helps: This benefits patients with type 1 diabetes who are looking for ways to better manage their condition alongside insulin therapy.

Plain English
This study looked at the mental health of Palestinian refugees in Egypt during the 2023 Gaza war, focusing on disorders like PTSD, anxiety, and depression. Of the 558 adults surveyed, 37.5% had PTSD, while 94.1% experienced anxiety and 94.8% faced depression. The findings highlight the urgent need for support strategies, especially since many refugees use unhealthy coping methods and face barriers like financial insecurity and difficulty accessing healthcare. Who this helps: This benefits Palestinian refugees struggling with mental health issues and the healthcare providers aiming to assist them.

Plain English
This study looked at how well drug product labels provide information on administering medications through enteral feeding tubes, which are used by people who have difficulty swallowing. Researchers reviewed 71 drug products and found that while 85% included information about the type of feeding tube, only 14% discussed the tube material, and just 18% explained how using these tubes affects the drug’s effectiveness. This matters because lack of clear information can lead to problems in safe and effective drug use, so better labeling and collaboration among stakeholders are needed. Who this helps: Patients who use enteral feeding tubes and their healthcare providers.

Plain English
This study focused on creating a new method for finding molecules that can bind to a protein called SLIT2, which plays important roles in nerve signals, immune responses, and cancer. The researchers developed a high-throughput process that uses temperature changes to detect binding interactions and measure how well these interactions can be disrupted, achieving consistent results even with very small amounts of material. This approach can help speed up the discovery of new treatments or drugs by providing a more efficient way to identify promising candidates. Who this helps: This benefits researchers and pharmaceutical companies looking to develop new therapies targeting SLIT2-related conditions.

Plain English
This study looked at kidney transplant patients who had heart problems, specifically atherosclerosis or coronary artery disease (CAD), before their surgery. The researchers found that these patients were 68% more likely to die after the transplant and nearly three times as likely to experience serious heart issues than those without CAD. Additionally, there was a small but meaningful increase in the risk of their kidney transplant failing. Who this helps: This helps kidney transplant patients with heart conditions and the doctors managing their care.

Plain English
This study looked at the outcomes of 105 cancer patients who were treated in the intensive care unit (ICU) at a hospital in Saudi Arabia over nine years. It found that nearly 40% of these patients died in the ICU, mainly due to worsening cancer, and that older patients, those with advanced cancer, and those suffering from respiratory infections were at a higher risk of mortality. Understanding these risk factors is crucial to improving care and support for cancer patients in critical conditions. Who this helps: This helps doctors and healthcare providers improve treatment for critically ill cancer patients.

Plain English
Researchers recently gathered in a workshop to discuss better ways to create medicines specifically for children. They talked about new testing methods that help understand how children's bodies absorb drugs, using advanced models that reflect real-life situations. Although they have made progress in this area, they noted that there is still more work to do to ensure drugs for kids are safe and effective. Who this helps: This helps children and their healthcare providers.

Plain English
The study looked at how many medications for children were developed into child-friendly forms when companies received time-limited patent extensions to encourage pediatric studies. Out of 321 drugs examined from 1998 to 2025, 235 got new approvals for use in kids, but many still used adult formulations that aren't ideal for children. For instance, 94% of studies for kids older than 12 used adult forms, while 85% of studies that did use child-friendly forms had products already available on the market. Who this helps: This benefits children and their caregivers by promoting safer, easier-to-administer medications.

Plain English
This study looked at the presence of norovirus, which causes stomach infections, in restaurants in Oman. Researchers tested 40 samples from dishcloths and tabletops and found norovirus RNA in 4 samples (10% total), with dishcloths having a higher contamination rate of 15%. This matters because it highlights that cleaning materials, especially dishcloths, can spread viruses more than the surfaces where food is served, urging restaurants to improve their cleaning methods. Who this helps: This helps restaurant staff and public health officials by promoting better sanitation practices to protect customers.

Plain English
This study looked at two important immune factors, LAG-3 and TREM2, that affect both Alzheimer's disease (AD) and cancer. It found that LAG-3 can help fight cancer effectively, while activating TREM2 can boost defense mechanisms in AD, but inhibiting it might be necessary when dealing with cancer cells. Understanding how to adjust therapies based on the disease can lead to better treatment strategies for both conditions. Who this helps: This benefits patients with Alzheimer's and cancer, as well as doctors treating these diseases.

Plain English
This study looked at how Ficus lyrata bark extract helps treat non-alcoholic fatty liver disease (NAFLD) in rats that were fed a high-fat diet for 12 weeks. The treatment significantly improved their health by lowering blood sugar, insulin levels, and liver enzymes while also enhancing lipid profiles. Specifically, the extract reduced the levels of genes and markers related to fat production and inflammation, leading to healthier liver conditions. Who this helps: Patients with non-alcoholic fatty liver disease.

Plain English
The study looked at whether adding steroid eye drops and a treatment called corneal cross-linking (CXL) could help people with bacterial corneal ulcers, which are serious eye infections. Out of nearly 2,000 people screened, 280 participants were treated, and the results showed no significant benefit from using steroids or CXL alongside standard antibiotic treatment after six months. In fact, using CXL along with steroids led to bigger scars compared to using steroids alone, meaning these additional treatments did not improve recovery compared to antibiotics alone. Who this helps: This information helps eye doctors better understand the effectiveness of current treatments for bacterial keratitis, allowing them to provide clearer guidance to patients.

Plain English
This study looked at how eating a lot of ultra-processed foods (UPFs), which are often low in nutrients but high in calories, affects the health of older adults, particularly their frailty and muscle strength. The researchers found that higher consumption of UPFs was linked to greater risks of frailty and muscle loss, with those eating more UPFs showing reduced grip strength and slower walking speeds. This is important because it highlights that changing eating habits by cutting back on UPFs could help older adults maintain their health and physical abilities. Who this helps: This helps older adults looking to improve their health, as well as healthcare providers seeking better strategies for managing frailty and sarcopenia.

Plain English
This study looked at how well a predictive model can identify when patients in hospitals might worsen based on nursing documentation from over 200 hospitals across the United States. The model successfully predicted patient deterioration, with 94% of the hospitals testing showing results equal to or better than the baseline performance. This is important because it suggests that using this model can help hospitals identify patients at risk more effectively, potentially leading to better patient outcomes. Who this helps: This benefits hospitals and healthcare providers by giving them tools to improve patient care.

Plain English
This research paper examined different strategies to help kidney transplant patients who have difficulty finding compatible donors due to high levels of antibodies. The study explored traditional methods like intravenous immunoglobulin combined with other therapies and newer options like Imlifidase and other targeted treatments, aiming to increase the success of transplants for these highly sensitized patients. This matters because successful desensitization can significantly improve transplant access and longevity for patients who would otherwise face long waiting times and limited options. Who this helps: This helps patients who are highly sensitized and struggling to find compatible kidney donors.

Plain English
This study looks at how fat stored in certain areas of the body, like around organs, can lead to health problems even if a person doesn't have a high overall body weight. It found that losing fat in these specific areas can improve health, particularly for metabolic and heart issues, more than just losing weight overall. For example, focusing on these fat deposits is a better approach to treatment than simply trying to reduce total body weight. Who this helps: This benefits patients dealing with obesity-related health issues.

Plain English
Researchers studied a protein called LAG-3 that is involved in cancer by making immune cells less effective. They found a new small molecule that is the strongest inhibitor of LAG-3 so far, increasing the immune response against cancer cells significantly, as it enhanced cancer cell killing and boosted a specific immune signal. This discovery is important because it may lead to new treatments that can better activate the immune system to fight cancer. Who this helps: Cancer patients seeking more effective immunotherapy options.

Plain English
This study looked at a disease called fascioliasis, which affects both humans and cattle in New Valley, Egypt. Researchers found that about 23% of cattle and 3.6% of people had this disease. Among the patients, most cases were diagnosed through stool tests and medical imaging, with more than half of the cases occurring in women, with an average age of 37. The findings underline the importance of a united approach to health, highlighting the connection between animal and human infections. Who this helps: This helps patients, farmers, and healthcare providers in understanding the disease and improving treatment and prevention strategies.

Plain English
Researchers studied the effects of the leaves from the Gliricidia sepium plant on kidney health in diabetic hamsters. They found that the plant extract significantly reduced harmful substances in the blood, such as inflammatory markers and waste products, suggesting it helps protect the kidneys in diabetes. This is important because it shows that a natural plant extract may provide a new way to help manage kidney damage in diabetic patients. Who this helps: Patients with diabetes and kidney issues.

Plain English
This study looked at how artemisinin, a compound derived from a plant, can help prevent early-stage bladder cancer in mice exposed to a cancer-causing chemical. The researchers found that giving artemisinin reduced the levels of certain cancer-related proteins and protected the mice's bladder and kidney functions. This is important because it shows that artemisinin might be a useful way to prevent bladder cancer in people at high risk. Who this helps: This helps patients at risk of bladder cancer.

Plain English
This study focused on improving the nutrition and overall well-being of older adults who participate in meal programs during the COVID-19 pandemic by providing digital education tailored to their cultural needs. Researchers engaged 398 older adults, offering in-person tech training and online nutrition education over a span of 20 weeks. The findings will help address food insecurity and enhance diet quality while also aiming to reduce loneliness and improve technology skills among participants. Who this helps: This benefits older adults who struggle with nutrition and technology access, especially during the pandemic.

Plain English
This study looked at how different factors affect the quality of life related to vision in patients treated for a serious eye infection called fungal keratitis, three months after their treatment. The researchers found that patients who experienced better vision (measured by visual acuity) had significantly higher quality of life scores, with a 1-point improvement in vision linked to a 13.4-point improvement in quality of life scores. Also, those who needed surgery faced worse quality of life outcomes compared to those receiving only medical treatment. Who this helps: This information benefits patients suffering from fungal keratitis by highlighting the importance of both vision improvement and the impact of treatment choices on their quality of life.

Plain English
This study focuses on a protein called LAG-3, which can prevent immune cells from attacking cancer. Researchers created new small molecules, called PROTACs, that specifically target and break down LAG-3. They found two PROTACs that efficiently reduced LAG-3 levels in cells, with effective concentrations of 0.27 µM and 0.42 µM, showing promise for new cancer treatments. Who this helps: This research benefits cancer patients by potentially improving immune responses against tumors.

Plain English
This study looked at how certain inflammation markers—interleukin-6 (IL-6), C-reactive protein (CRP), and high-sensitivity CRP (hsCRP)—affect outcomes for kidney transplant patients. It found that higher IL-6 levels increased the risk of graft dysfunction by 53% and all-cause death by 66%. Additionally, CRP was linked to a more than two-fold increase in overall mortality and a nearly seven-fold increase in the risk of cardiovascular issues. These findings are important because they suggest that tracking these inflammation markers could help in assessing risks for kidney transplant patients. Who this helps: This benefits kidney transplant patients and their doctors by providing information for better risk management.

Plain English
Researchers studied the SLIT2/ROBO1 signaling pathway, which is important for brain development, immune function, and cancer progression, particularly in glioblastoma. They discovered a new small molecule called DEL-S1 that effectively binds to SLIT2 and prevents its interaction with ROBO1, with a measured effectiveness (IC) of 68.8 micromolar. This discovery is significant because it opens up new possibilities for treating conditions linked to these proteins, such as certain brain cancers. Who this helps: This benefits patients with glioblastoma and other related conditions.

Plain English
This study looked at a newborn with serious digestive issues, including a stomach twist (gastric volvulus) and a blockage in the lower intestine caused by a fibrous band (ileal volvulus with atresia). Although tests indicated these problems, during surgery, doctors found a blockage in the lower intestine but did not find the stomach twist. The baby had surgery to remove part of the intestine and is recovering well. This case shows how important it is to carefully evaluate symptoms and test results when diagnosing intestinal blockages in newborns. Who this helps: This helps doctors working with newborns who have intestinal problems.

Plain English
This study examined the substances produced by a specific microorganism found in a marine snail called a nudibranch. Researchers analyzed its genetic material and discovered 36 groups of genes connected to the production of different compounds, identifying a total of 569 substances, including 86 that were clearly characterized. This research is important because it enhances our understanding of the unique biochemistry of marine microorganisms, which could lead to new applications in medicine and biotechnology. Who this helps: Patients, scientists, and industries involved in drug development and environmental studies.

Plain English
This study looked at how easy people in Saudi Arabia find it to use telehealth services, especially focusing on individuals with disabilities. Researchers surveyed 428 adults and found that disabled individuals felt the telehealth system was 80% less easy to use compared to those without disabilities. Key factors that made telehealth easier to use included having proper support, feeling safe, and how others perceived telehealth. Who this helps: This information can benefit patients, especially those with disabilities, by informing improvements to telehealth services.

Plain English
This study looked at how to better identify and treat neonatal sepsis—an infection that affects newborns—especially in places with limited medical resources. The review found that neonatal sepsis is the main cause of death in newborns, particularly in low- and middle-income countries, which account for 99% of cases. To improve survival rates, they propose practical solutions like using simple diagnostic tests, promoting Kangaroo Mother Care (holding infants skin-to-skin), and leveraging technology such as telemedicine and artificial intelligence. Who this helps: This research benefits newborns in low-resource settings and the healthcare workers caring for them.

Plain English
This study looked at why and how often pediatric research papers are retracted—meaning they were found to be unreliable—by analyzing 590 such cases from 1995 to 2024. The researchers found that retractions mainly happened in Asia, especially in China, and were often due to misconduct, with 37.5% linked to unethical practices. These findings highlight the need for better checks and rules to ensure that pediatric research is trustworthy, as most retractions occurred in 2023 and the overall rate of retracted papers is rising. Who this helps: This helps patients and their families by ensuring that pediatric medical research is reliable.

Plain English
Researchers examined the safety of new drugs for children, finding that while over 1,000 products have been studied for pediatric use in the last 20 years, there's a significant lack of attention on how these drugs might harm children's development. They emphasize the need to be aware of potential risks, such as those seen in the past with thalidomide, a drug that caused severe birth defects. Addressing these safety concerns is crucial to prevent another situation where a drug harms children's growth and development. Who this helps: Patients, particularly children using new medications.

Plain English
This study looked at a serious mix of two dangerous diabetes complications called diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS). It found that about one-third of patients show signs of both conditions at the same time, which makes it harder to diagnose and treat them; this overlap is associated with a higher risk of death compared to having just one condition. Understanding this overlap is important for creating better treatment plans, as patients face serious complications such as swelling in the brain and kidney damage. Who this helps: This helps doctors and healthcare teams manage high-risk diabetes patients more effectively.

Plain English
Researchers studied how to block the interaction between two proteins, SLIT2 and ROBO1, which play a role in tumor growth and immune evasion in brain cancer (glioblastoma). They successfully created and tested 20 new macrocyclic peptides, with two of them showing strong ability to inhibit the SLIT2/ROBO1 connection, specifically demonstrating 90% and 85% inhibition in tests. This work is important because it opens the door to new treatments for cancer by disrupting key processes that tumors use to grow and evade the immune system. Who this helps: This research helps patients with glioblastoma and other cancers, as well as doctors looking for effective therapies.

Plain English
This study looked at how two types of tiny particles—made from chitosan alone and ones loaded with curcumin (a compound found in turmeric)—can help treat chronic infections caused by Toxoplasma gondii in mice. The results showed that the mice treated with curcumin-loaded particles had the fewest brain cysts and healthier tissue in key organs compared to untreated mice. This matters because it indicates that these chitosan nanoparticles could be a new way to develop effective treatments for a common and serious infection. Who this helps: This benefits patients suffering from chronic Toxoplasma infections.

Plain English
This study looked at outbreaks of bacterial and fungal infections in hospitals during the COVID-19 pandemic. Researchers found that there were 619 cases of outbreaks, with Acinetobacter baumannii being the most common pathogen, causing a 59% death rate, and Candida auris, which had a 52% death rate. The study highlights the need for better infection control practices in healthcare settings to prevent future outbreaks, especially since two-thirds of the infections were resistant to multiple drugs. Who this helps: This benefits patients and healthcare workers alike, by improving safety in hospitals.

Plain English
This study looked at frailty, a decline in health that affects older adults, particularly those with chronic kidney disease who are on the waiting list for or have received a kidney transplant. Researchers found that frailty affects a significant number of patients, with 8.7% to 75% of candidates and 5.1% to 40.5% of recipients showing signs of frailty. Frailty is linked to worse outcomes, including higher death rates while waiting for a transplant, longer hospital stays, and complications after surgery, making it crucial to assess and manage frailty throughout the transplantation process. Who this helps: This research benefits patients waiting for kidney transplants and the doctors caring for them.

Plain English
This study looked at how disabilities affect healthcare access for Sudanese refugees in Egypt during the recent 2023 crisis. Researchers surveyed 531 refugees and found that those with chronic conditions and disabilities, like vision or mobility issues, faced greater difficulties in getting healthcare. For example, refugees with spinal diseases and diabetes had the toughest time accessing necessary treatment. This is important because it shows that refugees with disabilities are at a higher risk of not receiving the care they need, highlighting the need for specific support programs. Who this helps: This helps Sudanese refugees with disabilities and healthcare providers working in refugee support.

Plain English
This study looked at how people with disabilities feel about using telehealth services in Saudi Arabia and four other Arab countries: Egypt, Jordan, Libya, and Syria. Researchers found that 61% of individuals with disabilities reported low confidence in using these services. Key factors that affected their confidence included age, previous experience with telehealth, and the ease of use of the technology. This research is important because it highlights the need for better access to telehealth, especially in rural areas, and suggests that training and support can improve confidence for individuals with disabilities. Who this helps: This helps individuals with disabilities and healthcare providers working to improve telehealth services.

Plain English
This study looked at the role of dopamine, a brain chemical, not just in psychosis but also in depression, anxiety, and obsessive-compulsive disorder (OCD). The researchers found that issues with dopamine are linked to symptoms like lack of joy, motivation problems, and compulsive behaviors across these conditions. By recognizing dopamine's importance, doctors could develop better treatments tailored to individual needs, improving outcomes for many patients. Who this helps: Patients with depression, anxiety, and OCD.

Plain English
This study focused on a protein called CDK9 and how it affects certain types of aggressive T-cell lymphomas that are driven by another protein, GATA-3. The researchers found that CDK9 is crucial for the growth and survival of these lymphomas, suggesting that targeting CDK9 could be a new treatment strategy. This is important because it offers a potential way to overcome resistance to traditional chemotherapy in these cancers. Who this helps: This benefits patients with GATA-3 driven T-cell lymphomas.